Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Apr 1, 2027?
Yes price
1¢
No price
>99¢
Bid 1¢
Ask 10¢
Mid 6¢
About this market: Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Apr 1, 2027? is currently priced at 1¢ for Yes and >99¢ for No on kalshi, in the other category. It resolves on Apr 1, 2027 (6mo from now). Daily volume is around $0. No matched market was found on the other platform yet.
Cross-Platform Prices
More other markets
All other markets →
polymarket
Will Jesus Christ return before 2027?
2¢
$66.2M
kalshi
More tech layoffs in 2026 than in 2025?
94¢
$31.5M
kalshi
Will the U.S. confirm that aliens exist before 2027?
4¢
$28.3M
polymarket
Hantavirus pandemic in 2026?
2¢
$18.4M
kalshi
Will "SAVE Act" (H.R. 22) becomes law before Jan 4, 2027?
3¢
$13.9M
polymarket
Will there be at least 10000 measles cases in the U.S. in 20...
6¢
$6.5M
kalshi
Will Mitch McConnell resign his office early?
3¢
$3.7M
kalshi
Will Apple Inc. release iPhone 18 before Oct 1, 2026?
—¢
$3.5M